ZURICH, Jan 14 (Reuters) - A new Swiss production line where contract drugmaker Lonza (LONN.S), opens new tab is making active ingredients for Moderna's (MRNA.O), opens new tab COVID-19 vaccine is ...
Zacks Investment Research on MSN
CHMP backs EU approval of MRNA's new COVID-19 vaccine mNexSpike
Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the EU approval of mNexspike ...
The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback